Position
Entropy Technologies, LP in Capricor Therapeutics, Inc.
Back to the book · All holders of CAPR
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $11.2K$28.86 → $30.40
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 14.2K | $408.9K | — | — | — | 0.0% |
| Q1 2026 | 7.29K | $221.6K | $30.40 | $11.2K | −$198.6K | 0.0% |